ASX - By Stock
|
CYP |
Re:
Ann: FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
|
|
Rudder
|
153 |
28K |
0 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
153
|
28K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
|
|
Rudder
|
153 |
28K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
153
|
28K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
|
|
Rudder
|
153 |
28K |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
153
|
28K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
CYP Trading thread....
|
|
Rudder
|
69 |
12K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
69
|
12K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
CYP Trading thread....
|
|
Rudder
|
69 |
12K |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
69
|
12K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Rudder
|
59 |
29K |
3 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
59
|
29K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Rudder
|
59 |
29K |
16 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
59
|
29K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Rudder
|
10K |
3.0M |
4 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
Rudder
|
66 |
18K |
4 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
66
|
18K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
2 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
394
|
86K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
MST Access values CYP at $2.76
|
|
Rudder
|
112 |
19K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
112
|
19K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
MST Access values CYP at $2.76
|
|
Rudder
|
112 |
19K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
112
|
19K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
MST Access values CYP at $2.76
|
|
Rudder
|
112 |
19K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
112
|
19K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Trading Halt
|
|
Rudder
|
45 |
16K |
4 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
45
|
16K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: AGM Presentation
|
|
Rudder
|
13 |
4.6K |
2 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
13
|
4.6K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Ceasing to be a Director
|
|
Rudder
|
16 |
13K |
12 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
16
|
13K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Results of Meeting
|
|
Rudder
|
206 |
100K |
5 |
21/11/21 |
21/11/21 |
ASX - By Stock
|
206
|
100K
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Rudder
|
33K |
16M |
4 |
17/11/21 |
17/11/21 |
Charts
|
33K
|
16M
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY - Institutional Investor Presentation
|
|
Rudder
|
17 |
5.7K |
4 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
17
|
5.7K
|
4
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Chairman's Address to Shareholders
|
|
Rudder
|
36 |
9.7K |
0 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
36
|
9.7K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Chairman's Address to Shareholders
|
|
Rudder
|
36 |
9.7K |
0 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
36
|
9.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY - Institutional Investor Presentation
|
|
Rudder
|
17 |
5.7K |
3 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
17
|
5.7K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
2 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
394
|
86K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
1 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
394
|
86K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Rudder
|
394 |
86K |
1 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
394
|
86K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
Rudder
|
25 |
8.2K |
0 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
25
|
8.2K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
Rudder
|
115 |
18K |
3 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
115
|
18K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
Rudder
|
115 |
18K |
5 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
115
|
18K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Momentum & Belief
|
|
Rudder
|
48 |
23K |
6 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
48
|
23K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Momentum & Belief
|
|
Rudder
|
48 |
23K |
0 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
48
|
23K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
Rudder
|
115 |
18K |
4 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
115
|
18K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
Rudder
|
115 |
18K |
1 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
115
|
18K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Rudder
|
25K |
12M |
2 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
25K
|
12M
|
2
|
|
ASX - By Stock
|
TI1 |
Re:
Tombador Open Source forecast Model
|
|
Rudder
|
86 |
22K |
5 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
86
|
22K
|
5
|
|
ASX - By Stock
|
TI1 |
Re:
News From Brazil
|
|
Rudder
|
80 |
20K |
1 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
80
|
20K
|
1
|
|
ASX - By Stock
|
TI1 |
Re:
News From Brazil
|
|
Rudder
|
80 |
20K |
0 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
80
|
20K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
News From Brazil
|
|
Rudder
|
80 |
20K |
0 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
80
|
20K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
News From Brazil
|
|
Rudder
|
80 |
20K |
1 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
80
|
20K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Rudder
|
33K |
16M |
24 |
21/10/21 |
21/10/21 |
Charts
|
33K
|
16M
|
24
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Rudder
|
33K |
16M |
5 |
21/10/21 |
21/10/21 |
Charts
|
33K
|
16M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Rudder
|
130 |
85K |
8 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
130
|
85K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Rudder
|
130 |
85K |
1 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
130
|
85K
|
1
|
|